Grail (NASDAQ: GRAL) revenue
Grail reported revenue of $147.2m for fiscal 2025, 17.2% more than in fiscal 2024 ($125.6m). Since fiscal 2023 its revenue has grown by 58.1%, an average growth of 25.7% a year.
Grail has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 3 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $147.2m | +17.2% | −$562.2m | −382.0% |
| 2024 | $125.6m | +34.9% | −$2,189m | −1,743.0% |
| 2023 | $93.1m | — | −$1,515m | −1,627.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Grail revenue compared with its sector
By revenue for its latest fiscal year, Grail ranks 264th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Grail, 17.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 262nd | AirSculpt Technologies | $151.8m | −15.8% |
| 263rd | MacroGenics | $149.5m | −0.3% |
| 264th | Grail | $147.2m | 17.2% |
| 265th | Karyopharm Therapeutics | $146.1m | 0.6% |
| 266th | InfuSystem | $143.4m | 6.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Grail
- How much revenue did Grail make in fiscal 2025?
- Grail reported revenue of $147.2m for fiscal 2025, compared with $125.6m in fiscal 2024.
- How much has the revenue of Grail grown?
- Between fiscal 2023 and fiscal 2025 it went from $93.1m to $147.2m: 58.1% more, an average growth of 25.7% a year.
- What was the best year for revenue at Grail?
- Of its last 3 fiscal years, fiscal 2025, with $147.2m.
- Where does Grail rank in its sector by revenue?
- It ranks 264th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Grail come from?
- From the annual report (Form 10-K) that Grail files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Grail files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Grail: the Grail page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.